Since tissue plasminogen activator was approved by the Food and Drug Administration in 1996 for the dissolution of blood clots in the brain that cause strokes, it has been the primary treatment for stroke victims. But two new wire-mesh systems offer a different approach.
New devices successfully pluck blood clots out of the brain
Send us a letter
Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.